mxdbg, there has been much criticism of current management?...

mxdbg, there has been much criticism of current management?
Personally I don't agree with a lot that has been said in the past, I see this as a smart move, what they have done is add some positive leverage to the purchase price of BIT225 because it means that if a large farmer thought they could buy the license for it for sale as something that can kill the covid19 virus, they would get the coverage of other indications as well, it has to be worth more than just that one indication, and this move would have to help IMHO.

What this does is tell prospective buyers that they will have to stump up more for BIT225 due to the fact that it covers multiple indications, but in doing so, they will get the jump on some of the other compounds that Biotron have been working on wrt Covid19, but it will allow Biotron to at some point allow for the licensing of a single indication drug for Covid19, this to me was a smart move and I would like to congratulate management for doing so.